As 2022 comes to a close, we would like to thank our 35 member organisations & over 200 expert clinicians and consumers who generously contribute their time and expertise.
➡️ https://t.co/aDERPbHffs
@CochraneAus#clinicalevidence#COVID19#MPX
222 Australians died from COVID this week; 15000 new cases were reported nationally…
… and this week our government defunded the national taskforce assessing best practice care and research into COVID19.
https//:https://t.co/x4jZnxpEmA via @evidence_aus
📣 HELP SHAPE THE GUIDELINES!
We want to identify the uses, impacts, strengths & opportunities for improvement in the ongoing work of the T/force & our guidelines.
We're inviting Australian clinicians to participate in a brief survey.
Please share: https://t.co/91cPtumPow
We're taking a break😎. We'll continue to conduct global evidence surveillance & will convene relevant panel meetings should new research warrant an important change in practice for the treatment of #COVID19 in Australia.
Our next guidelines update is scheduled for Feb 4, 2021
Happy AHP day to our @TEAMtrialICU team. We have recruited 96% of our target sample size with only 30 patients to go. What an amazing effort during the pandemic!
New Burnet study shows how mandatory #mask use turned around Melbourne's COVID-19 second wave. #Delta's emergence means that masks are even more important now. "The key finding from this study is that masks work". @CrabbBrendan@normanswan@KnowC19_Burnet https://t.co/cFjZyrlZDI
With the recent #COVID19 outbreak across Australia, it’s timely to revisit what happens if you test positive with COVID-19. With so much media commentary and coverage from all over the globe it can be hard for consumers to sort fact from fiction.
Read:https://t.co/dZfiif7APD
ICU patients with type 2 diabetes currently receive the same blood sugar treatment as other patients.
Ongoing research by @AlexPPoole and @MelbourneICU investigates a personalised approach, and the results could have far reaching impacts https://t.co/fNyQoOmSTA
#NDW2021
We've now published our consensus guidance on the use of P2/N95 respirators, surgical masks & eye protection. Developed by the joint Taskforce/ICEG Infection Prevention & Control Panel & approved by 32 Taskforce member organisations. Read here: https://t.co/3xk4ZrmNfV
WEBINAR: @CHFofAustralia are hosting 'What are Living Guidelines & how are consumers involved?' next Tuesday 27/4.
Learn how leading clinicians, evidence experts & people with lived experience are working together to develop trustworthy guidelines.
👉 https://t.co/67Bn3MlYrW